Pulmonx (LUNG) Interest & Investment Income (2019 - 2025)
Pulmonx's (LUNG) quarterly Interest & Investment Income came in at $611000.0 in Q3 2025, down 51.85% year-over-year from $1.3 million in Q3 2024, and down 15.49% quarter-over-quarter from $723000.0 in Q2 2025.
Powered by 
Analysis
Pulmonx (LUNG) Interest & Investment Income (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Interest & Investment Income for 7 consecutive years, with $611000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Interest & Investment Income fell 51.85% year-over-year to $611000.0 in Q3 2025; TTM through Sep 2025 was $3.2 million, a 41.64% decrease from a year earlier, with the FY2024 full-year figure at $5.1 million, down 9.11% from the prior year.
- Interest & Investment Income was $611000.0 for Q3 2025 at Pulmonx, down from $723000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.5 million in Q4 2023 and troughed at $94000.0 in Q4 2021.
- A 5-year average of $776631.6 and a median of $748000.0 in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 1000.0% in 2021 and plunged 51.85% in 2025, its largest moves.
- Over 5 years, Interest & Investment Income stood at $94000.0 in 2021, then surged by 695.74% to $748000.0 in 2022, then surged by 106.02% to $1.5 million in 2023, then sank by 32.19% to $1.0 million in 2024, then plunged by 41.53% to $611000.0 in 2025.
- The last three Interest & Investment Income figures came in at $611000.0 (Q3 2025), $723000.0 (Q2 2025), and $864000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | - |
| 10 | Pulmonx | 75.73 Mn | 5.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 611,000.00 |
| Jun 30, 2025 | 723,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 748,000.00 |
| Sep 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Mar 31, 2022 | 105,000.00 |
| Dec 31, 2021 | 94,000.00 |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Mar 31, 2021 | 105,000.00 |
| Dec 31, 2020 | 115,000.00 |